PAVM News and Press, PAVmed Inc. From 08/17/22

Gainers: Blue Water Vaccines ( BWV ) +57% . Eargo ( EAR ) +49% . Cassava Sciences ( SAVA ) +29% . MiNK Therapeutics ( INKT ) +24% . Cogent Biosciences ( COGT ) +16% . Losers: Blueprint Medicines ( BPMC ) -22% ....

Blueprint Medicines ( BPMC ) -13% on reports to seek label expansion for systemic mastocytosis therapy after trial win . Artelo Biosciences ( ARTL ) -13% . Krispy Kreme ( DNUT ) -12% on Q2 earnings release . Forza X1 ( FRZA ) -12% . ...

PAVmed Inc. (PAVM) Q2 2022 Earnings Conference Call August 16, 2022, 04:30 PM ET Company Participants Adrian Miller - VP, IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Conference Call Participants Ross Osborn - Cantor Fitzgeral...

PAVmed press release ( NASDAQ: PAVM ): Q2 Non-GAAP EPS of -$0.17 beats by $0.03 . PAVmed had cash and cash equivalents of $65.2 million as of June 30, 2022, compared with $77.3 million as of December 31, 2021. Shares +3.03% . For further details see: ...

Lucid’s EsoGuard test volume grows 60% and LucidDx Labs fully operational Veris Health Cancer Care Platform to commercially launch this year Conference call to be held today at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Com...

EsoGuard test volume increased 60% for quarter and over 300% annually CLIA-Certified LucidDx Labs fully operational and billing as an independent entity Conference call to be held today at 4:30 PM EDT Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Luc...

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentat...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...

Patients in Orange County, Dallas-Fort Worth, Palm Beach County, and Columbus, Ohio now have access to a brief, non-invasive, office-based test to detect esophageal precancer before it progresses to deadly esophageal cancer Lucid Diagnostics Inc. (Nasdaq: LUCD) (...

Updates best practice advice to support non-endoscopic esophageal precancer screening and significantly expands target population to include, for the first time, at-risk patients without chronic heartburn symptoms Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lu...